Conformation-dependent GAD65 autoantibodies in diabetes

Diabetologia

Volumn 47, Issue 9, 2004, Pages 1581-1591

  Luo, D ^a   Gilliam, L K ^a   Greenbaum, C ^b   Bekris, L ^a   Hampe, C S ^a   Daniels, T ^a   Richter, W ^c   Marcovina, S M ^a   Rolandsson, O ^d   Landin Olsson, M ^e   Kockum, I ^f   Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UMEÅ UNIVERSITY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoantibody; Autoimmunity; Epitope; GAD65; Latent autoimmune diabetes in adults; Type 1 diabetes; Type 2 diabetes

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; EPITOPE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMIC ACID; PROLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CHILD; CONFORMATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELATIVE; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BASE SEQUENCE; BINDING SITES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FAMILY; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION; RABBITS; REFERENCE VALUES;

EID: 5644244334     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1495-3     Document Type: Article

References (42)

1. Falorni A, Kockum I, Sanjeevi CB, Lernmark Å (1995) Pathogenesis of insulin-dependent diabetes mellitus. Baillieres Clin Endocrinol Metab 9:25-46
2. Karlsen AE, Hagopian WA, Grubin CE et al. (1991) Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88:8337-8341
3. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
4. Hampe CS, Hammerle LP, Bekris L et al. (2000) Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 85:4671-4679
5. Bingley PJ, Bonifacio E, Mueller PW (2003) Diabetes antibody standardization program: First assay proficiency evaluation. Diabetes 52:1128-1136
6. Rolandsson O, Hägg E, Nilsson M, Hallmans G, Lernmark Å (2001) Prediction of diabetes by screening with body mass index, oral glucose tolerance test (OGT) and islet cell autoantibodies in a regional population. J Internal Med 249:279-288
7. Rolandsson O, Hägg E, Hampe C et al. (1999) Levels of glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies in the general population are related to glucose intolerance and body mass index. Diabetologia 42:555-559
8. Hao W, Davis C, Hirsch IB et al. (1999) Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a two year study. J Neurology 246:731-735
9. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP (1999) Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes-Follow-up of the Seattle Family Study. Diabetes 48:170-175
10. Verge CF, Gianani R, Kawasaki E et al. (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933
11. Richter W, Eiermann TH, Endl J et al. (1993) Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 36:785-790
12. Schwartz HL, Chandonia JM, Kash SF et al. (1999) High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287:983-999
13. Daw K, Powers AC (1995) Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes. Diabetes 44:216-220
14. Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818-825
15. Sohnlein P, Muller M, Syren K et al. (2000) Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type 1 diabetes. The Childhood Diabetes in Finland Study Group. Diabetologia 43:210-217
16. Falorni A, Gambelunghe G, Forini F et al. (2000) Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 85:309-316
17. Richter W, Endl J, Eiermann TH et al. (1992) Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 89:8467-8471
18. Falorni A, Ackefors M, Carlberg C et al. (1996) Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM. Diabetologia 39:1091-1098
19. Hampe CS, Lundgren P, Daniels TL et al. (2001) A novel monoclonal antibody specific for the N-terminal end of GAD65. J Neuroimmunology 113:63-71
20. Chang YC, Gottlieb DI (1988) Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neuroscience 8:2123-2130
21. Richter W, Shi Y, Baekkeskov S (1993) Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 90:2832-2836
22. Ludvigsson J, Heding L, Liedén G, Marner B, Lernmark Å (1983) Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J 286:176-178
23. Li L, Jiang J, Hagopian WA et al. (1995) Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies. J Histochem Cytochem 43:53-59
24. Schranz DB, Bekris L, Landin O-M et al. (1998) A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. J Immunol Methods 213:87-97
25. Torn C, Landin Olsson M, Ostman J et al. (2000) Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 16:442-447
26. Hampe CS, Ortqvist E, Rolandsson O et al. (1999) Species-specific autoantibodies in type 1 diabetes. J Clin Endocrinol Metab 84:643-648
27. Mire-Sluis AR, Das RG, Lernmark Å (2000) The World Health Organization International Collaborative Study for Islet Cell Antibodies. Diabetologia 43:1282-1292
28. Notkins AL, Lernmark Å (2001) Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108:1247-1252
29. Bingley PJ, Bonifacio E, Williams AJK et al. (1997) Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710
30. Hagopian WA, Sanjeevi CB, Kockum I et al. (1995) Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511
31. Hagopian WA, Karlsen AE, Gottsater A et al. (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374
32. Turner R, Stratton I, Horton V et al. (1997) UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293
33. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310
34. Kim J, Namchuck M, Bugawan T et al. (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595-606
35. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560
36. Dinkel K, Meinck H, Jury KM, Karges W, Richter W (1998) Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194-201
37. Syren K, Lindsay L, Stoehrer B et al. (1996) Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 157:5208-5214
38. Richter W, Northemann W, Müller M, Böhm BO (1996) Mapping of an autoreactive epitope with glutamate decarboxylase using a diabetes-associated monoclonal antibody and an epitope cDNA library. Hybridoma 15:103-108
39. Powers AC, Eisenbarth GS (1985) Autoimmunity to islet cells in diabetes mellitus. Ann Rev Med 36:533-544
40. Tree TIM, Morgenthaler NG, Duhindan N et al. (2000) Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by type 1 diabetic autoantibodies. Diabetologia 43:881-889
41. Bonifacio E, Lernmark Å, Dawkins RL (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106:83-88
42. Mire-Sluis AR, Das RG, Lernmark Å (1999) The development of a World Health Organisation international standard for islet cell antibodies: The aims and design of an international collaborative study. Diabetes Metab Res Rev 15:72-77